Position in INVA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$43,980,381
-$3,150,741 QoQ
Shares Held
1,887,570
-19.9% QoQ
Ownership
2.56%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 99.90797692271015.ToString("F0")%
Shared 0.ToString("F0")%
None 0.09202307728984886.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $1,767,735,657 across 48 Biotechnology names. INVA ranks #10 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
638,950 | $285,316,733 | |
| 2 | INCY |
Incyte Corp
|
2,830,799 | $266,434,801 | |
| 3 | EXEL |
Exelixis, Inc.
|
4,834,625 | $207,357,066 | |
| 4 | GMAB |
Genmab A/S
|
4,975,324 | $133,487,942 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
171,571 | $132,562,617 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,918,149 | $123,969,969 | |
| 7 | RPRX |
Royalty Pharma plc
|
2,010,398 | $96,438,792 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
737,859 | $55,405,832 |
All Filings in INVA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,980,381 | 1,887,570 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $47,131,122 | 2,357,735 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $43,045,052 | 2,358,633 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $34,323,403 | 1,708,482 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $16,717,183 | 922,073 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $19,887,316 | 1,146,243 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $20,567,100 | 1,065,101 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,636,555 | 404,668 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,071,923 | 464,037 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,724,792 | 232,219 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,529,117 | 117,715 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,322,130 | 182,414 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $1,565,222 | 118,130 | Shares | Defined | 2023-02-14 | |
| 2022-06-30 | $5,709,596 | 386,829 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $29,559,195 | 1,527,607 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,308,889 | 1,583,124 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $23,713,628 | 1,419,128 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $9,306,647 | 694,008 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $12,295,892 | 1,028,945 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $19,286,831 | 1,556,645 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $16,266,940 | 1,556,645 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $21,870,941 | 1,564,445 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $18,428,449 | 1,567,045 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||